Download PDF
Deutsche Zeitschrift für Onkologie 2020; 52(02): 70-72
DOI: 10.1055/a-1167-6035
Forschung

Kurzzeitfasten unter Chemotherapie

Verbessert Kurzzeitfasten die Wirksamkeit einer Chemotherapie und vermindert Nebenwirkungen?
Petra Voiß
1   Integrative Onkologie/Naturheilkunde, Klinik für Senologie/Interdisziplinäres Brustkrebszentrum, KEM Evang. Kliniken Essen-Mitte, Essen
,
Petra Klose
1   Integrative Onkologie/Naturheilkunde, Klinik für Senologie/Interdisziplinäres Brustkrebszentrum, KEM Evang. Kliniken Essen-Mitte, Essen
,
Sherko Kümmel
2   Klinik für Senologie/Interdisziplinäres Brustkrebszentrum, KEM|Evang. Kliniken Essen-Mitte, Essen
,
für die AGIMed der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) › Author Affiliations
› Further Information
    Permissions and Reprints

2016 erhielt der Japaner Yoshinori Ohsumi den Nobelpreis für die Entdeckung der Mechanismen der Autophagie, des Selbstverdauungs- und Wiederverwertungsprozesses der Zellen. Dieser Mechanismus trägt dazu bei, das Gleichgewicht zwischen dem Abbau alter und der Produktion neuer Zellkomponenten herzustellen. Auch krankhafte oder krankmachende Strukturen, eingedrungene Bakterien und Viren werden so entsorgt. Eine fehlregulierte autophagische Aktivität kann umgekehrt zu einem zellulären Desaster führen und sich in unterschiedlichsten Krankheiten manifestieren.



Publication History

Article published online:
28 June 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Harvie MN, Howell T. Could intermittent energy restriction and intermittent fasting reduce rates of cancer in obese, overweight, and normal-weight subjects? A summary of evidence. Adv Nutr 2016; 7: 690-705
    CrossrefPubMedGoogle Scholar
  • 2 Gabel K, Hoddy KK, Haggerty N. et al. Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study. Nutr Healthy Aging 2018; 4: 345-353
    PubMedGoogle Scholar
  • 3 Dommerholt MB, Dionne DA, Hutchinson DF. et al. Metabolic effects of short-term caloric restriction in mice with reduced insulin gene dosage. J Endocrinol 2018; 237: 59-71
    CrossrefPubMedGoogle Scholar
  • 4 Wei M, Brandhorst S, Shelehchi M. et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 2017; 9: eai8700
    CrossrefPubMedGoogle Scholar
  • 5 Michalsen A, Li C. Fasting therapy for treating and preventing disease – current state of evidence. Forsch Komplementmed 2013; 20: 444-453
    CrossrefPubMedGoogle Scholar
  • 6 Lv M, Zhu X, Wang H. et al. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. PLoS One 2014; 9: e115147
    CrossrefPubMedGoogle Scholar
  • 7 Antunes F, Erustes AG, Costa AJ. et al. Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics (Sao Paulo) 2018; 73 (Suppl. 01) e814s
    PubMedGoogle Scholar
  • 8 Castoldi F, Vacchelli E, Zitvogel L. et al. Systemic autophagy in the therapeutic response to anthracycline-based Chemotherapy. Oncoimmunology 2019; 8: e1498285
    CrossrefPubMedGoogle Scholar
  • 9 van Niekerk G, Hattingh SM, Engelbrecht AM. Enhanced therapeutic efficacy in cancer patients by short-term fasting: The autophagy connection. Front Oncol 2016; 6: 242
    PubMedGoogle Scholar
  • 10 Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Meta 2014; 19: 181-192
    PubMedGoogle Scholar
  • 11 Raffaghello L, Lee C, Safdie FM. et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA 2008; 105: 8215-8220
    CrossrefPubMedGoogle Scholar
  • 12 O’Flanagan CH, Smith LA, McDonell SB, Hursting SD. When less may be more: calorie restriction and response to cancer therapy. BMC Med 2017; 15: 106
    CrossrefPubMedGoogle Scholar
  • 13 Caffa I, D'Agostino V, Damonte P. et al. Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget 2015; 20: 11820-11832
    PubMedGoogle Scholar
  • 14 Di Biase S, Shim HS, Kim KH. et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biol 2017; 15: e2001951
    CrossrefPubMedGoogle Scholar
  • 15 Pietrocola F, Pol J, Vacchelli E. et al. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 2016; 30: 147-160
    CrossrefPubMedGoogle Scholar
  • 16 Safdie FM, Dorff T, Quinn D. et al. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 2009; 1: 988-1007
    CrossrefPubMedGoogle Scholar
  • 17 Dorff TB, Groshen S, Garcia A. et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 2016; 16: 360
    CrossrefPubMedGoogle Scholar
  • 18 De Groot S, Vreeswijk MP, Welters MJ. et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 2015; 15: 652
    CrossrefPubMedGoogle Scholar
  • 19 Bauersfeld SP, Kessler CS, Wischnewsky M. et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer 2018; 18: 476
    CrossrefPubMedGoogle Scholar
  • 20 Dorff TB, Shelechi M, Kang I. et al. A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy. ASCO – Abstract 4. Juni. 2018 https://meetinglibrary.asco.org/record/165536/abstract. Stand: 28.02.2019
    PubMedGoogle Scholar